Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

Vincenzo Cerullo, Iulia Diaconu, Lotta Kangasniemi, Maria Rajecki, Sophie Escutenaire, Anniina Koski, Valentina Romano, Noora Rouvinen, Tamara Tuuminen, Leena Laasonen, Kaarina Partanen, Satu Kauppinen, Timo Joensuu, Minna Oksanen, Sirkka-Liisa Holm, Elina Haavisto, Aila Karioja-Kallio, Anna Kanerva, Sari Pesonen, Petteri T. Arstila & 1 andra Akseli Hemminki

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftMolecular therapy
Volym19
Utgåva9
Sidor (från-till)1737-1746
Antal sidor10
ISSN1525-0016
DOI
StatusPublicerad - 2011
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3111 Biomedicinska vetenskaper

Citera det här

Cerullo, Vincenzo ; Diaconu, Iulia ; Kangasniemi, Lotta ; Rajecki, Maria ; Escutenaire, Sophie ; Koski, Anniina ; Romano, Valentina ; Rouvinen, Noora ; Tuuminen, Tamara ; Laasonen, Leena ; Partanen, Kaarina ; Kauppinen, Satu ; Joensuu, Timo ; Oksanen, Minna ; Holm, Sirkka-Liisa ; Haavisto, Elina ; Karioja-Kallio, Aila ; Kanerva, Anna ; Pesonen, Sari ; Arstila, Petteri T. ; Hemminki, Akseli. / Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus. I: Molecular therapy. 2011 ; Vol. 19, Nr. 9. s. 1737-1746.
@article{40829c8715d8495d9036fdce36349709,
title = "Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus",
keywords = "REGULATORY T-CELLS, METRONOMIC ORAL CYCLOPHOSPHAMIDE, REFRACTORY SOLID TUMORS, PERIPHERAL-BLOOD, IMMUNE-RESPONSE, TERMINAL CANCER, PHASE-II, IMMUNOTHERAPY, REPLICATION, CARCINOMA, 3111 Biomedicine",
author = "Vincenzo Cerullo and Iulia Diaconu and Lotta Kangasniemi and Maria Rajecki and Sophie Escutenaire and Anniina Koski and Valentina Romano and Noora Rouvinen and Tamara Tuuminen and Leena Laasonen and Kaarina Partanen and Satu Kauppinen and Timo Joensuu and Minna Oksanen and Sirkka-Liisa Holm and Elina Haavisto and Aila Karioja-Kallio and Anna Kanerva and Sari Pesonen and Arstila, {Petteri T.} and Akseli Hemminki",
year = "2011",
doi = "10.1038/mt.2011.113",
language = "English",
volume = "19",
pages = "1737--1746",
journal = "Molecular therapy",
issn = "1525-0016",
publisher = "Cell Press",
number = "9",

}

Cerullo, V, Diaconu, I, Kangasniemi, L, Rajecki, M, Escutenaire, S, Koski, A, Romano, V, Rouvinen, N, Tuuminen, T, Laasonen, L, Partanen, K, Kauppinen, S, Joensuu, T, Oksanen, M, Holm, S-L, Haavisto, E, Karioja-Kallio, A, Kanerva, A, Pesonen, S, Arstila, PT & Hemminki, A 2011, 'Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus', Molecular therapy, vol. 19, nr. 9, s. 1737-1746. https://doi.org/10.1038/mt.2011.113

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus. / Cerullo, Vincenzo; Diaconu, Iulia; Kangasniemi, Lotta; Rajecki, Maria; Escutenaire, Sophie; Koski, Anniina; Romano, Valentina; Rouvinen, Noora; Tuuminen, Tamara; Laasonen, Leena; Partanen, Kaarina; Kauppinen, Satu; Joensuu, Timo; Oksanen, Minna; Holm, Sirkka-Liisa; Haavisto, Elina; Karioja-Kallio, Aila; Kanerva, Anna; Pesonen, Sari; Arstila, Petteri T.; Hemminki, Akseli.

I: Molecular therapy, Vol. 19, Nr. 9, 2011, s. 1737-1746.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

AU - Cerullo, Vincenzo

AU - Diaconu, Iulia

AU - Kangasniemi, Lotta

AU - Rajecki, Maria

AU - Escutenaire, Sophie

AU - Koski, Anniina

AU - Romano, Valentina

AU - Rouvinen, Noora

AU - Tuuminen, Tamara

AU - Laasonen, Leena

AU - Partanen, Kaarina

AU - Kauppinen, Satu

AU - Joensuu, Timo

AU - Oksanen, Minna

AU - Holm, Sirkka-Liisa

AU - Haavisto, Elina

AU - Karioja-Kallio, Aila

AU - Kanerva, Anna

AU - Pesonen, Sari

AU - Arstila, Petteri T.

AU - Hemminki, Akseli

PY - 2011

Y1 - 2011

KW - REGULATORY T-CELLS

KW - METRONOMIC ORAL CYCLOPHOSPHAMIDE

KW - REFRACTORY SOLID TUMORS

KW - PERIPHERAL-BLOOD

KW - IMMUNE-RESPONSE

KW - TERMINAL CANCER

KW - PHASE-II

KW - IMMUNOTHERAPY

KW - REPLICATION

KW - CARCINOMA

KW - 3111 Biomedicine

U2 - 10.1038/mt.2011.113

DO - 10.1038/mt.2011.113

M3 - Article

VL - 19

SP - 1737

EP - 1746

JO - Molecular therapy

JF - Molecular therapy

SN - 1525-0016

IS - 9

ER -